Dongbang Medical Co., Ltd (KOSDAQ:240550)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,580.00
-90.00 (-1.59%)
Sep 11, 2026, 3:30 PM KST

Dongbang Medical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
16,11911,7032,9149,7753,192
Depreciation & Amortization
7,3707,0216,1645,4485,272
Loss (Gain) From Sale of Assets
-267.52-181.98-1,986102.6528.47
Loss (Gain) From Sale of Investments
-3.07-1.769.92-1.73.79
Loss (Gain) on Equity Investments
1,5801,457717.75665.49534.16
Stock-Based Compensation
203.46291.13401.28601.08480.63
Provision & Write-off of Bad Debts
-224.16137.37492.31-1,4621,895
Other Operating Activities
4,1841,66111,5994,8021,949
Change in Accounts Receivable
982.39-2,422-2,521485.17-2,442
Change in Inventory
-7,219-5,685-1,604-4,460-6,410
Change in Accounts Payable
995.182,177989.57-4,4132,453
Change in Other Net Operating Assets
-7,505-4,1341,420-5,2663,518
Operating Cash Flow
16,21512,02418,5486,27610,474
Operating Cash Flow Growth
3.16%-35.18%195.54%-40.08%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-22,450-14,528-13,140-4,465-6,095
Sale of Property, Plant & Equipment
864.53688.21101.2514.98217.75
Cash Acquisitions
---3,552--
Sale (Purchase) of Intangibles
-207.97-172.86-40.54-209.41-187.83
Sale (Purchase) of Real Estate
-626.34-15.85---112.17
Investment in Securities
-3,669-5,807-11,048-3,682-62.99
Other Investing Activities
1,3711,505-1,58612.814
Investing Cash Flow
-26,565-20,267-17,676-7,731-6,712

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Short-Term Debt Issued
-15,7127,0008,20714,678
Long-Term Debt Issued
-1,1101,4832,9005,070
Total Debt Issued
23,56016,8228,48311,10719,748
Short-Term Debt Repaid
--17,736-5,652-9,438-17,450
Long-Term Debt Repaid
--10,112-3,319-5,195-2,367
Total Debt Repaid
-15,786-27,847-8,971-14,633-19,816
Net Debt Issued (Repaid)
7,773-11,025-487.88-3,526-68.17
Issuance of Common Stock
47831,787256.6145.47-
Other Financing Activities
2,4043,2200.92-0-11,794
Financing Cash Flow
10,65523,982-230.35-3,4813,138

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
1,127-466.37988.15-100.0424.76
Miscellaneous Cash Flow Adjustments
-0-0---
Net Cash Flow
1,43215,2731,630-5,0366,925

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-6,235-2,5055,4081,8114,379
Free Cash Flow Growth
--198.58%-58.64%-
Free Cash Flow Margin
-4.98%-2.21%5.15%1.99%5.38%
Free Cash Flow Per Share
-296.12-120.64334.19103.53295.08
Levered Free Cash Flow
-9,541-4,902-13,835-1,527-
Unlevered Free Cash Flow
-8,841-4,191-12,613106.5-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
941.941,0491,2192,0581,113
Cash Income Tax Paid
3,5174,8503,0911,6422,544
Change in Working Capital
-12,746-10,064-1,764-13,654-2,881